STOCK TITAN

ScanSource CEO exercises options, sells 77K shares

ScanSource’s CEO exercised 77,339 options at $37 and sold the resulting shares in open-market trades at weighted average prices in the mid‑$50s.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SCANSOURCE, INC. (SCSC) reported that Chief Executive Officer, President and Board Chair Michael L. Baur exercised vested employee stock options and sold the resulting shares. On September 10 and 11, 2026, he exercised options for a total of 77,339 shares of common stock at an exercise price of $37.00 per share and acquired the same number of shares.

On those same dates he sold an aggregate of 77,339 shares of common stock in open-market transactions at weighted average prices in the mid‑$50s per share, with the reported price ranges from about $55.07 to $58.61 depending on the trade group. No Rule 10b5-1 trading plan is reported for these transactions, and the filing does not state his resulting share ownership.

Positive

  • None.

Negative

  • None.
Insider BAUR MICHAEL L
Role CEO, President, BOD Chair
Sold 77,339 shs ($4.44M)
Approx. gross sale proceeds $4.44M
Approx. exercise cost $2.86M
Approx. pre-tax spread $1.58M
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) F6 57,359 $0.00 $0.00
Exercise Common Stock 57,359 $37.00 $2.12M
Sale Common Stock F3 1,851 $56.50 $105K
Sale Common Stock F4 6,692 $57.71 $386K
Sale Common Stock F5 48,816 $58.14 $2.84M
Exercise Employee Stock Option (Right to Buy) F6 19,980 $0.00 $0.00
Exercise Common Stock 19,980 $37.00 $739K
Sale Common Stock F1 18,080 $55.39 $1.00M
Sale Common Stock F2 1,900 $57.03 $108K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 200,698 shares (Direct)
Footnotes (6)
  1. F1. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.07 to $55.80 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.12 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.92 to $56.87 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.96 to $57.94 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.96 to $58.61 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The option vested in one-third increments on the anniversary of the grant date on 12/2/2017, 12/2/2018 and 12/2/2019.
Options exercised 77,339 shares Total employee stock options exercised by the CEO on September 10–11, 2026
Exercise price $37.00 per share Exercise price for the employee stock options converted into common stock
Shares sold 77,339 shares Total ScanSource common shares sold in open-market transactions on September 10–11, 2026
Sale price range (first group) $55.07–$55.80 per share Price range for 18,080 shares sold, reported as a weighted average price with this range
Sale price range (largest block) $57.96–$58.61 per share Price range for 48,816 shares sold, reported as a weighted average price with this range
Option expiration date December 2, 2026 Scheduled expiration for the exercised employee stock options
Employee Stock Option financial
"Employee Stock Option (Right to Buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
weighted average price financial
"The price reported in column 4 is the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
multiple transactions financial
"These shares were sold in multiple transactions at prices ranging from"
grant date financial
"The option vested in one-third increments on the anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did SCSC’s CEO report on this Form 4?

Michael L. Baur reported exercising vested employee stock options for 77,339 shares of ScanSource common stock at an exercise price of $37.00 per share on September 10 and 11, 2026, and selling the same total number of shares in open-market transactions on those dates.

How many ScanSource (SCSC) shares did the CEO sell and at what prices?

He sold an aggregate of 77,339 shares of ScanSource common stock in multiple open‑market trades. Weighted average sale prices were around the mid‑$50s per share, with reported price ranges from about $55.07 to $58.61, depending on the specific trade group described in the footnotes.

What options did the CEO of SCSC exercise in this filing?

He exercised employee stock options covering 77,339 shares of ScanSource common stock at an exercise price of $37.00 per share. The options were scheduled to expire on December 2, 2026 and had vested in one‑third increments on December 2, 2017, 2018 and 2019.

Were the SCSC insider sales made under a Rule 10b5-1 plan?

No. The filing indicates that these transactions were not made pursuant to a Rule 10b5‑1 trading plan, as the related certification box is not checked and no footnote describes them as made under such a plan.

On what dates did the SCSC CEO trade shares reported in this Form 4?

All reported transactions occurred on September 10, 2026 and September 11, 2026. On each date, Michael L. Baur exercised options to acquire shares at $37.00 per share and sold blocks of common stock in multiple open‑market trades at weighted average prices disclosed in the footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BAUR MICHAEL L

(Last)(First)(Middle)
6 LOGUE COURT

(Street)
GREENVILLE SOUTH CAROLINA 29615

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SCANSOURCE, INC. [ SCSC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO, President, BOD Chair
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/10/2026M19,980A$37220,678D
Common Stock09/10/2026S18,080D$55.39(1)202,598D
Common Stock09/10/2026S1,900D$57.03(2)200,698D
Common Stock09/11/2026M57,359A$37258,057D
Common Stock09/11/2026S1,851D$56.5(3)256,206D
Common Stock09/11/2026S6,692D$57.71(4)249,514D
Common Stock09/11/2026S48,816D$58.14(5)200,698D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$3709/10/2026M19,980 (6)12/02/2026Common Stock19,980$0.0057,359D
Employee Stock Option (Right to Buy)$3709/11/2026M57,359 (6)12/02/2026Common Stock57,359$0.000D
Explanation of Responses:
1. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.07 to $55.80 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.12 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $55.92 to $56.87 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.96 to $57.94 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.96 to $58.61 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The option vested in one-third increments on the anniversary of the grant date on 12/2/2017, 12/2/2018 and 12/2/2019.
J. Creighton Lynes, attorney-in-fact09/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading